TABLE 3

Change in Height in Siblings With CH Over the Course of L-thyroxine Treatment

VisitsPatient 1Patient 2Patient 3
Age (y)Height SDHeight (cm)Δ Height (SDS)Age (y)Height SDHeight (cm)Δ Height (SDS)Age (y)Height SDHeight (cm)Δ Height (SDS)
Initial14.8–7.589.1N/A7.7−8.184N/A0.5–8.152.2N/A
Year 115.8–7.493.10.18.7−6.298.21.91.5–2.9735.2
Year 216.7–8.399.8–0.99.6−4.91071.32.4–2.382.30.6
Year 317.8–8.7107.7–0.410.7−3.81161.13.6–2.291.10.1
Year 418.9–8.1116.00.611.8−4.1125.2−0.34.6–1.9980.3
Year 519.4–8.0117.50.112.3−4.1128.00.05.1–1.7101.50.2
Year 620.6a–6.9126.51.113.6−3.5136.70.66.4–1.41100.3
Year 721.5–6.1134.40.814.4−2.9142.20.67.2–1.5115.9−0.1
Year 822.0–5.2136.00.915.0−2.07148.60.838.0–1.3120.60.2
  • N/A, not applicable; SDS, SD score.

  • a Growth hormone therapy was started